03/27/2020
3:50 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2020
8:15 PM | Cesca Therapeutics (Filer)
| Form 424B5
| |
03/24/2020
2:31 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2020
4:22 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
4:26 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2020
6:56 PM | Boyalife Asset Holding II, Inc. (Reporting)
Boyalife Group, Inc. (Reporting)
Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
3:58 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
12:57 PM | RENAISSANCE TECHNOLOGIES LLC (Filed by)
Cesca Therapeutics (Subject)
| Form SC 13G
| |
01/09/2020
2:05 PM | Donaghy Debra (Reporting)
Cesca Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/06/2020
4:20 PM | Cesca Therapeutics (Filer)
| Form 424B5
| |
01/05/2020
11:15 PM | Cesca Therapeutics (Filer)
| Form EFFECT
| |
01/03/2020
6:16 PM | Boyalife Ltd (0001667753) (Reporting)
Boyalife Asset Holding II, Inc. (Reporting)
Boyalife Group, Inc. (Reporting)
Li Yishu (Reporting)
Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2019
4:29 PM | Cesca Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/27/2019
11:19 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2019
11:18 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2019
4:27 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2019
3:23 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2019
1:40 PM | Cesca Therapeutics (Filer)
| Form NT 10-Q
| |
10/31/2019
1:35 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2019
9:00 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2019
9:00 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2019
1:34 PM | Cesca Therapeutics (Filer)
| Form 8-K/A
| |
09/18/2019
5:42 PM | Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2019
5:40 PM | Cesca Therapeutics (Issuer)
Westgate Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2019
5:39 PM | Cesca Therapeutics (Issuer)
MEDFORD RUSSELL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2019
4:07 PM | Cesca Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/06/2019
4:26 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2019
4:27 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2019
11:47 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2019
3:34 PM | Cesca Therapeutics (Filer)
| Form SD
Specialized Disclosure Report | |
06/26/2019
1:51 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2019
2:02 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2019
11:15 PM | Cesca Therapeutics (Filer)
| Form EFFECT
| |
05/14/2019
3:22 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2019
3:15 PM | Cesca Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2019
2:34 PM | Cesca Therapeutics (Filer)
| Form DEFA14A
| |
04/30/2019
2:42 PM | Cesca Therapeutics (Filer)
| Form DEF 14A
| |
04/10/2019
11:49 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2019
1:16 PM | Cesca Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2019
3:22 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2019
1:20 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2019
12:44 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2019
9:09 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2019
3:29 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2018
12:51 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2018
7:00 PM | Cauble Jeffery (Reporting)
Cesca Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
6:57 PM | Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2018
4:01 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2018
11:15 PM | Cesca Therapeutics (Filer)
| Form EFFECT
| |
09/19/2018
2:18 PM | Cesca Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/19/2018
2:13 PM | Cesca Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/05/2018
1:48 PM | Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2018
4:32 PM | Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2018
5:05 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2018
11:28 AM | Cesca Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2018
3:15 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2018
3:16 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2018
6:57 PM | Cesca Therapeutics (Issuer)
Xu James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
3:58 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2018
2:45 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2018
4:26 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2018
11:41 AM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2018
11:48 AM | Cesca Therapeutics (Filer)
| Form SD
Specialized Disclosure Report | |
05/25/2018
3:11 PM | Cesca Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G
| |
05/22/2018
4:18 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2018
4:16 PM | Cesca Therapeutics (Filer)
| Form DEFA14A
| |
05/18/2018
4:21 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2018
2:45 PM | Cesca Therapeutics (Filer)
| Form POS EX
| |
05/16/2018
11:15 PM | Cesca Therapeutics (Filer)
| Form EFFECT
| |
05/16/2018
4:17 PM | Cesca Therapeutics (Filer)
| Form S-1MEF
| |
05/16/2018
5:04 AM | Cesca Therapeutics (Filer)
| Form S-1/A
| |
05/14/2018
4:17 PM | Cesca Therapeutics (Filer)
| Form S-1/A
| |
05/14/2018
3:09 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2018
4:15 PM | Cesca Therapeutics (Subject)
| Form FWP
| |
05/08/2018
4:09 PM | Cesca Therapeutics (Filer)
| Form S-1/A
| |
05/07/2018
3:06 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2018
5:54 PM | Boyalife Asset Holding II, Inc. (Reporting)
Boyalife Group, Inc. (Reporting)
Cesca Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/18/2018
6:51 PM | Cesca Therapeutics (Issuer)
Li Yishu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
6:50 PM | Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
4:42 PM | Cesca Therapeutics (Issuer)
Xu James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
4:40 PM | Cesca Therapeutics (Issuer)
MEDFORD RUSSELL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
4:40 PM | Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
4:38 PM | Cesca Therapeutics (Issuer)
Westgate Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
4:05 PM | Cesca Therapeutics (Filer)
| Form PRE 14A
| |
04/17/2018
8:41 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2018
8:39 PM | Cesca Therapeutics (Filer)
| Form DEFA14A
| |
04/12/2018
9:24 AM | Cesca Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/06/2018
3:34 PM | Cesca Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/30/2018
9:45 AM | Cesca Therapeutics (Filer)
| Form CT ORDER
| |
03/28/2018
3:38 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2018
3:31 PM | Cesca Therapeutics (Filer)
| Form 424B5
| |
03/22/2018
3:40 PM | Cesca Therapeutics (Filer)
| Form 10-KT
| |
03/22/2018
3:22 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/16/2018
12:45 PM | Cesca Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2018
7:03 PM | Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
7:03 PM | Cesca Therapeutics (Issuer)
Westgate Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
7:02 PM | Cesca Therapeutics (Issuer)
Xu James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
7:01 PM | Cesca Therapeutics (Issuer)
MEDFORD RUSSELL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2018
4:21 PM | Cesca Therapeutics (Filer)
| Form RW
| |
02/05/2018
6:02 AM | Cesca Therapeutics (Filer)
| Form S-1/A
| |
